Joan E. Wither

60 Leonard Ave
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications

Characterizing arthritis subtypes in lupus: prevalence, clinical features and role of type I interferon signatures.

Characterizing arthritis subtypes in lupus: prevalence, clinical features and role of type I interferon signatures.

Journal: Rheumatology (Oxford, England)
Published: March 07, 2026

Type I interferons enhance B cell activation and promote differentiation of double negative 2 cells in SLE.

Type I interferons enhance B cell activation and promote differentiation of double negative 2 cells in SLE.

Journal: Lupus science & medicine
Published: March 06, 2026

Type I Interferon status and clinical manifestations in a large cohort of patients with systemic lupus erythematosus.

Type I Interferon status and clinical manifestations in a large cohort of patients with systemic lupus erythematosus.

Journal: Joint bone spine
Published: February 25, 2026

Type I Interferon Status and Clinical Manifestations in a Large Cohort of Patients with Systemic Lupus Erythematosus.

Type I Interferon Status and Clinical Manifestations in a Large Cohort of Patients with Systemic Lupus Erythematosus.

Journal: Joint bone spine
Published: February 25, 2026

Elevated serum brain injury markers are associated with disease activity, pro-inflammatory cytokine levels and cognitive dysfunction in adolescents with childhood-onset SLE.

Elevated serum brain injury markers are associated with disease activity, pro-inflammatory cytokine levels and cognitive dysfunction in adolescents with childhood-onset SLE.

Journal: Lupus science & medicine
Published: December 08, 2025

Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes.

Measurements of urinary biomarkers at 2 years following a lupus nephritis flare are associated with subsequent renal outcomes.

Journal: Lupus science & medicine
Published: June 29, 2025

Lupus nephritis II: Treatment and monitoring.

Lupus nephritis II: Treatment and monitoring.

Journal: Advances in clinical chemistry
Published: April 04, 2025

Intraindividual cognitive function course over time in patients with systemic lupus erythematosus.

Intraindividual cognitive function course over time in patients with systemic lupus erythematosus.

Journal: RMD open
Published: March 10, 2025

Lupus nephritis: Biomarkers.

Lupus nephritis: Biomarkers.

Journal: Advances in clinical chemistry
Published: January 16, 2025

Sex differences in serum proteomic profiles in psoriatic arthritis.

Sex differences in serum proteomic profiles in psoriatic arthritis.

Journal: Rheumatology (Oxford, England)
Published: December 13, 2024

Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis.

Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis.

Journal: Journal of autoimmunity
Published: November 29, 2024

Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody-Positive Individuals.

Differences in IgG Sialylation Distinguish Asymptomatic From Symptomatic Antinuclear Antibody-Positive Individuals.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 16, 2024
Showing 1-12 of 76

Last Updated: 09/26/2026